» Articles » PMID: 23242185

Extracellular Guanosine Regulates Extracellular Adenosine Levels

Overview
Specialties Cell Biology
Physiology
Date 2012 Dec 18
PMID 23242185
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this investigation was to test the hypothesis that extracellular guanosine regulates extracellular adenosine levels. Rat preglomerular vascular smooth muscle cells were incubated with adenosine, guanosine, or both. Guanosine (30 μmol/l) per se had little effect on extracellular adenosine levels. Extracellular adenosine levels 1 h after addition of adenosine (3 μmol/l) were 0.125 ± 0.020 μmol/l, indicating rapid disposition of extracellular adenosine. Extracellular adenosine levels 1 h after addition of adenosine (3 μmol/l) plus guanosine (30 μmol/l) were 1.173 ± 0.061 μmol/l, indicating slow disposition of extracellular adenosine. Cell injury increased extracellular levels of endogenous adenosine and guanosine, and the effects of cell injury on endogenous extracellular adenosine were modulated by altering the levels of endogenous extracellular guanosine with exogenous purine nucleoside phosphorylase (converts guanosine to guanine) or 8-aminoguanosine (inhibits purine nucleoside phosphorylase). Extracellular guanosine also slowed the disposition of extracellular adenosine in rat preglomerular vascular endothelial cells, mesangial cells, cardiac fibroblasts, and kidney epithelial cells and in human aortic and coronary artery vascular smooth muscle cells and coronary artery endothelial cells. The effects of guanosine on adenosine levels were not mimicked or attenuated by 5-iodotubericidin (adenosine kinase inhibitor), erythro-9-(2-hydroxy-3-nonyl)-adenine (adenosine deaminase inhibitor), 5-aminoimidazole-4-carboxamide (guanine deaminase inhibitor), aristeromycin (S-adenosylhomocysteine hydrolase inhibitor), low sodium (inhibits concentrative nucleoside transporters), S-(4-nitrobenzyl)-6-thioinosine [inhibits equilibrative nucleoside transporter (ENT) type 1], zidovudine (inhibits ENT type 2), or acadesine (known modulator of adenosine levels). Guanosine also increases extracellular inosine, uridine, thymidine, and cytidine, yet decreases extracellular uric acid. In conclusion, extracellular guanosine regulates extracellular adenosine levels.

Citing Articles

Development of Optical-Based Molecularly Imprinted Nanosensors for Adenosine Detection.

Kurt Z, Cimen D, Denizli A, Bereli N ACS Omega. 2023; 8(21):18839-18850.

PMID: 37273602 PMC: 10233842. DOI: 10.1021/acsomega.3c01028.


Integrating metabolomics and network pharmacology to assess the effects of quercetin on lung inflammatory injury induced by human respiratory syncytial virus.

Sun Y, Zhao P, Zhu C, Jiang M, Li X, Tao J Sci Rep. 2023; 13(1):8051.

PMID: 37198253 PMC: 10192330. DOI: 10.1038/s41598-023-35272-8.


Dynamic and Rapid Detection of Guanosine during Ischemia.

Weese-Myers M, Cryan M, Witt C, Caldwell K, Modi B, Ross A ACS Chem Neurosci. 2023; 14(9):1646-1658.

PMID: 37040534 PMC: 10265669. DOI: 10.1021/acschemneuro.3c00048.


The role of astrocytes in epileptic disorders.

Hayatdavoudi P, Hosseini M, Hajali V, Hosseini A, Rajabian A Physiol Rep. 2022; 10(6):e15239.

PMID: 35343625 PMC: 8958496. DOI: 10.14814/phy2.15239.


Study on the Active Constituents and Molecular Mechanism of Zhishi Xiebai Guizhi Decoction in the Treatment of CHD Based on UPLC-UESI-Q Exactive Focus, Gene Expression Profiling, Network Pharmacology, and Experimental Validation.

Liu Y, He X, Di Z, Du X ACS Omega. 2022; 7(5):3925-3939.

PMID: 35155889 PMC: 8829943. DOI: 10.1021/acsomega.1c04491.


References
1.
Gessi S, Merighi S, Fazzi D, Stefanelli A, Varani K, Borea P . Adenosine receptor targeting in health and disease. Expert Opin Investig Drugs. 2011; 20(12):1591-609. DOI: 10.1517/13543784.2011.627853. View

2.
Siaw M, Mitchell B, Koller C, Coleman M, HUTTON J . ATP depletion as a consequence of adenosine deaminase inhibition in man. Proc Natl Acad Sci U S A. 1980; 77(10):6157-61. PMC: 350233. DOI: 10.1073/pnas.77.10.6157. View

3.
Jackson E, Dubey R . Role of the extracellular cAMP-adenosine pathway in renal physiology. Am J Physiol Renal Physiol. 2001; 281(4):F597-612. DOI: 10.1152/ajprenal.2001.281.4.F597. View

4.
Ugarkar B, DaRe J, Kopcho J, Browne 3rd C, Schanzer J, Wiesner J . Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. J Med Chem. 2000; 43(15):2883-93. DOI: 10.1021/jm000024g. View

5.
Guinzberg R, Cortes D, Diaz-Cruz A, Riveros-Rosas H, Villalobos-Molina R, Pina E . Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors. Am J Physiol Endocrinol Metab. 2005; 290(5):E940-51. DOI: 10.1152/ajpendo.00173.2005. View